Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension

Slides: 13–16 of 16
Add to tray Remove from tray

Evidence on Adverse Effects: Angioedema

Keywords: serious adverse event | angioedema | ACEIs | DRI
Add to tray Remove from tray

Gaps in Knowledge

Keywords: gaps in knowledge | future research | subgroups | clinical trials
Add to tray Remove from tray

Patient Cost Information

Keywords: adherence | antihypertensive agents | generic | wholesale | cost
Add to tray Remove from tray

What To Discuss With Your Patients

Keywords: barriers | blood pressure medication | shared decisionmaking | tradeoffs | patients
Pages: Previous 1 [2]
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364